Correction: PCI Biotech: Mandatory notification regarding trade of shares
Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member Hilde Furberg.
After the transaction, Hilde Furberg and her related parties holds 8,000 shares in PCI Biotech.
Release updated with attachment.
This information is subject to the disclosure requirements in MAR (regulation (EU) No. 596/2014 on market abuse) as implemented in Norway in accordance with section 3-1 of the Securities Trading Act.
Attachment
